Martin C, Viviand X, Saux P, Gouin F
Department of Anesthesia and Intensive Care, Hôpital Sainte-Marguerite, Marseilles University Hospital System, Marseilles School of Medicine, France.
Crit Care Med. 1999 Dec;27(12):2626-9. doi: 10.1097/00003246-199912000-00004.
To determine the frequency of central venous catheter-induced thrombosis of the axillary vein.
Prospective, controlled study.
Tertiary care university center.
Sixty patients in a medical-surgical intensive care unit who required central venous catheterization via the axillary vein.
Single-lumen, silicone elastomer or polyurethane catheters were inserted for a mean duration of 14.7+/-7.4 days (range, 4-33 days). On catheter removal, bilateral upper-extremity phlebographic examination was performed in each patient. The incidence of deep vein thrombosis in catheterized arms was compared with that in uncatheterized arms.
Of the 60 patients who underwent axillary vein cannulation, one patient had clinical signs of arm vein thrombosis, but no patient had clinical sign of pulmonary embolism. There were 35 patients (58.3%) who developed positive phlebographic examinations homolateral to the catheter. Fibrin sleeves that developed around the catheters were observed in 28 patients (47%). Five patients (8.3%) had phlebographic signs of partial axillary vein thrombosis: nonobstructive clots adherent to the vessel wall and/or the catheter. Two patients (3.3%) had phlebographic signs of complete axillary vein thrombosis. No thrombosis was observed in patients with catheterizations lasting < or =6 days, two cases were observed for duration of 7-14 days, and five cases were observed for duration of > or =15 days (p < .01). In the seven patients with axillary vein thrombosis, the vessel was cannulated with fewer than three puncture attempts, and the mean duration for catheter insertion (10+/-2.5 min) was not different from that of patients with no axillary vein thrombosis (14+/-9 min).
Based on the data from the present study, we conclude that axillary vein catheterization is associated with a 11.6% frequency of upper-extremity deep vein thrombosis. This rate of vein thrombosis is similar to that observed after internal jugular or subclavian vein cannulation. Given the acceptable rate of this clinically important complication, axillary vein cannulation offers an attractive alternative site for catheter insertion to the internal jugular or subclavian vein in the critically ill. Because thrombosis is rare or absent in catheterizations lasting <15 days, it seems wise to withdraw axillary catheters after a maximum of 2 wks.
确定经腋静脉中心静脉置管引起腋静脉血栓形成的发生率。
前瞻性对照研究。
三级医疗大学中心。
60例在内科-外科重症监护病房需要经腋静脉进行中心静脉置管的患者。
插入单腔硅胶或聚氨酯导管,平均留置时间为14.7±7.4天(范围4 - 33天)。拔除导管时,对每位患者进行双侧上肢静脉造影检查。比较置管侧上肢深静脉血栓形成的发生率与未置管侧上肢的发生率。
在60例行腋静脉置管的患者中,1例有上肢静脉血栓形成的临床体征,但无患者有肺栓塞的临床体征。35例患者(58.3%)静脉造影显示导管同侧阳性。28例患者(47%)观察到导管周围形成纤维蛋白套。5例患者(8.3%)有腋静脉部分血栓形成的静脉造影征象:非阻塞性血栓附着于血管壁和/或导管。2例患者(3.3%)有腋静脉完全血栓形成的静脉造影征象。置管时间≤6天的患者未观察到血栓形成,7 - 14天观察到2例,≥15天观察到5例(p <.01)。在7例腋静脉血栓形成的患者中,静脉穿刺次数少于3次,导管插入的平均时间(10±2.5分钟)与无腋静脉血栓形成的患者(14±9分钟)无差异。
根据本研究数据,我们得出结论,经腋静脉置管与上肢深静脉血栓形成的发生率为11.6%相关。这种静脉血栓形成率与经颈内静脉或锁骨下静脉置管后观察到的发生率相似。鉴于这种具有临床重要性的并发症发生率可接受,经腋静脉置管为重症患者提供了一个有吸引力的替代颈内静脉或锁骨下静脉的导管插入部位。由于置管时间<15天的患者血栓形成罕见或无血栓形成,最多2周后拔除腋静脉导管似乎是明智的。